ERBB3 and breast carcinoma: For example, IGF1R is overexpressed in HER2+ breast cancer, and forms a heteromeric complex with HER2 and HER3 to activate the PI3K signaling pathway, conferring trastuzumab resistance to breast cancer patients48.